190 related articles for article (PubMed ID: 15315976)
21. Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndrome.
Zipursky A; Wang H; Brown EJ; Squire J
Blood; 1994 Oct; 84(7):2278-82. PubMed ID: 7919346
[TBL] [Abstract][Full Text] [Related]
22. Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias.
Brizard F; Brizard A; Guilhot F; Tanzer J; Berger R
Leukemia; 1994 Jun; 8(6):1005-11. PubMed ID: 8207973
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage.
van Lom K; Hagemeijer A; Smit E; Hählen K; Groeneveld K; Löwenberg B
Leukemia; 1995 Nov; 9(11):1818-21. PubMed ID: 7475268
[TBL] [Abstract][Full Text] [Related]
24. [Detection of trisomy 8 and monosomy 7 in chronic granulocytic leukemia and myelodysplastic syndrome by cytogenetic analysis and fluorescence in situ hybridization].
Szabó Gabriella P; Balogh E; Jakab Z; Germán P; Bodnár F; Kiss A; Telek B; Oláh E
Orv Hetil; 2002 Dec; 143(50):2775-9. PubMed ID: 12583317
[TBL] [Abstract][Full Text] [Related]
25. Trisomy 8 and monosomy 7 detected in bone marrow using primed in situ labeling, fluorescence in situ hybridization, and conventional cytogenetic analyses. A study of 54 cases with hematological disorders.
Yan J; Zhang XX; Fetni R; Drouin R
Cancer Genet Cytogenet; 2001 Feb; 125(1):30-40. PubMed ID: 11297765
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation.
Hopfer O; Komor M; Koehler IS; Schulze M; Hoelzer D; Thiel E; Hofmann WK
Exp Hematol; 2007 May; 35(5):712-23. PubMed ID: 17577921
[TBL] [Abstract][Full Text] [Related]
27. Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na.
Olnes MJ; Shenoy A; Weinstein B; Pfannes L; Loeliger K; Tucker Z; Tian X; Kwak M; Wilhelm F; Yong AS; Maric I; Maniar M; Scheinberg P; Groopman J; Young NS; Sloand EM
Leuk Res; 2012 Aug; 36(8):982-9. PubMed ID: 22524974
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
Pellagatti A; Cazzola M; Giagounidis AA; Malcovati L; Porta MG; Killick S; Campbell LJ; Wang L; Langford CF; Fidler C; Oscier D; Aul C; Wainscoat JS; Boultwood J
Blood; 2006 Jul; 108(1):337-45. PubMed ID: 16527891
[TBL] [Abstract][Full Text] [Related]
29. Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission.
Engel H; Goodacre A; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Andreeff M
Br J Haematol; 1997 Oct; 99(1):64-75. PubMed ID: 9359505
[TBL] [Abstract][Full Text] [Related]
30. Prognostic features of patients with myelodysplastic syndromes aged < 50 years: update of a single-institution experience.
Breccia M; Finsinger P; Loglisci G; Santopietro M; Salaroli A; Serrao A; Latagliata R; Volpicelli P; Petrucci L; Nanni M; Alimena G
Leuk Lymphoma; 2012 Dec; 53(12):2439-43. PubMed ID: 22647078
[TBL] [Abstract][Full Text] [Related]
31. The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes.
Nilsson L; Edén P; Olsson E; Månsson R; Astrand-Grundström I; Strömbeck B; Theilgaard-Mönch K; Anderson K; Hast R; Hellström-Lindberg E; Samuelsson J; Bergh G; Nerlov C; Johansson B; Sigvardsson M; Borg A; Jacobsen SE
Blood; 2007 Oct; 110(8):3005-14. PubMed ID: 17616640
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings.
Rigolin GM; Porta MD; Bugli AM; Castagnari B; Mauro E; Bragotti LZ; Ciccone M; Cuneo A; Castoldi G
Eur J Haematol; 2004 Nov; 73(5):351-8. PubMed ID: 15458514
[TBL] [Abstract][Full Text] [Related]
33. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome.
Dostalova Merkerova M; Krejcik Z; Votavova H; Belickova M; Vasikova A; Cermak J
Eur J Hum Genet; 2011 Mar; 19(3):313-9. PubMed ID: 21150891
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes.
Hast R; Eriksson M; Widell S; Arvidsson I; Bemell P
Leuk Res; 1999 Jun; 23(6):579-84. PubMed ID: 10374851
[TBL] [Abstract][Full Text] [Related]
36. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
[TBL] [Abstract][Full Text] [Related]
38. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics.
Virtaneva K; Wright FA; Tanner SM; Yuan B; Lemon WJ; Caligiuri MA; Bloomfield CD; de La Chapelle A; Krahe R
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1124-9. PubMed ID: 11158605
[TBL] [Abstract][Full Text] [Related]
39. Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting.
Miura I; Kobayashi Y; Takahashi N; Saitoh K; Miura AB
Br J Haematol; 2000 Sep; 110(4):876-9. PubMed ID: 11054073
[TBL] [Abstract][Full Text] [Related]
40. Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome.
Prall WC; Czibere A; Grall F; Spentzos D; Steidl U; Giagounidis AAN; Kuendgen A; Otu H; Rong A; Libermann TA; Germing U; Gattermann N; Haas R; Aivado M
Int J Hematol; 2009 Mar; 89(2):173-187. PubMed ID: 19152102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
